Kuros Biosciences AG / Key word(s): Miscellaneous02-Jun-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 KRThe issuer is solely responsible for the content of this announcement. MagnetOs U.S. Q1 sales accelerate, rising 117% over Q1 2020 European distribution network expansion ahead of sche...